Loading market dashboard

Estimates, scoring, valuation assumptions, and peer comparison in one research surface.
Beijing Tong Ren Tang Chinese Medicine Company Limited · Forecast overview
Bars show expected revenue while the line tracks expected EPS.
| Period | Revenue avg | Revenue range | EBITDA | EPS avg | Analysts |
|---|---|---|---|---|---|
| Dec 2028 | $258.20M | $256.16M - $260.23M | $96.47M | $0.111 | 1 |
| Dec 2027 | $238.36M | $235.29M - $241.43M | $89.05M | $0.086 | 2 |
| Dec 2026 | $213.59M | $213.09M - $214.09M | $79.80M | $0.076 | 2 |
| Dec 2025 | $225.48M | $224.56M - $226.39M | $84.24M | $0.081 | 2 |
| Dec 2024 | $202.11M | $188.22M - $216.00M | $75.51M | $0.078 | 2 |
| Dec 2023 | $195.19M | $193.90M - $196.47M | $79.69M | $0.08 | 1 |
| Dec 2022 | $204.43M | $203.09M - $205.78M | $83.47M | $0.091 | 1 |
| Dec 2021 | $192.35M | $191.08M - $193.61M | $78.53M | $0.092 | 1 |
| Dec 2020 | $140.47M | $139.55M - $141.40M | $57.35M | $0.07 | 1 |
| Dec 2019 | $193.45M | $192.18M - $194.72M | $78.98M | $0.092 | 1 |
| Dec 2018 | $191.22M | $189.97M - $192.48M | $78.07M | $0.083 | 1 |
| Dec 2017 | $159.14M | $158.09M - $160.19M | $64.97M | $0.07 | 1 |